Shigeki Tabata
Papers
2
Total Citations
7
H-Index
2
About
Shigeki Tabata is a pioneering surgeon and researcher whose work sits at the intersection of advanced robotic surgery and cutting-edge cancer immunotherapy. His key contributions span two distinct but equally impactful fields: minimally invasive cardiac surgery and peptide-based dendritic cell immunotherapy. In cardiac surgery, Tabata demonstrated the feasibility of robotically assisted multivessel minimally invasive direct coronary artery bypass grafting (MIDCAB) using bilateral internal thoracic arteries, a technically demanding procedure that reduces patient trauma and recovery time. His 2007 case report on this technique remains a foundational reference in robotic cardiac surgery. In oncology, Tabata reported a landmark case of a stage IV gastric cancer patient who achieved complete remission after receiving multi-peptide dendritic cell immunotherapy targeting WT1, MUC1, Her-2, and survivin, combined with standard chemotherapy. This 2015 report, though modest in citation count, exemplifies a personalized, multi-targeted approach to immunotherapy that has inspired further clinical investigation into combination treatment strategies for advanced malignancies. Tabata’s dual expertise highlights his commitment to translating complex surgical and immunological innovations into tangible patient outcomes, making him a notable figure in both robotic surgery and cancer immunotherapy research.
Research Focus
Key Achievements
Top Papers
- 1
- 2